Holdings

Sands Capital Alternatives, LLC

As of Sep 30, 2026, Sands Capital Alternatives, LLC reported 23 positions worth US$689M. Largest: Alamar Biosciences, Inc., Nu Holdings Ltd. and Beta Bionics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Alamar Biosciences, Inc.4.23MUS$144Mno changeSep 30, 2026
Nu Holdings Ltd.6.99MUS$88.5M−103KSep 30, 2026
Beta Bionics, Inc.4MUS$75.9M+290KSep 30, 2026
SpyGlass Pharma, Inc.2.5MUS$65Mno changeSep 30, 2026
Klaviyo, Inc. Series A3.83MUS$60.2M−101KSep 30, 2026
10x Genomics, Inc.482KUS$43.5Mno changeSep 30, 2026
Inhibikase Therapeutics, Inc.13MUS$26.8Mno changeSep 30, 2026
Cerebras Systems Inc.122KUS$21.8M+89,659Sep 30, 2026
DoorDash, Inc.107KUS$19.7M−20,261Sep 30, 2026
Odyssey Therapeutics, Inc.875KUS$19.4Mno changeSep 30, 2026